tesofensine vs semaglutide vs. GLP-1 Agonists: Comparing Weight Loss Efficacy ๐๐ผ๐๐ณ ๐๐ผ๐ ๐๐ฎ๐ป๐ ๐๐ฒ๐ถ๐ด๐ต๐-๐น๐ผ๐๐ ๐๐๐ฝ๐ฝ๐ผ๐ฟ๐
Description
Oral semaglutide was also a treatment arm before, so the 14 milligram dose led to an A1C reduction of 1.3%
The dose escalation to maintenance levels means all three receptor pathways are being activated at therapeutic concentrations
Accessed 20 May 2024
There is limited data on drug-drug interactions, however, patients on drugs that affect motility or those on pharmaceuticals that have a narrow therapeutic window require careful oversight
Dans ce cas, Purotyn GLP-1 sintgre comme un soutien complmentaire une alimentation quilibre et une activit physique rgulire, sans remplacer ces fondamentaux
